KP Tissue Inc. (TSE:KPT - Get Free Report) reached a new 52-week low on Wednesday . The stock traded as low as C$7.99 and last traded at C$8.00, with a volume of 106677 shares trading hands. The stock had previously closed at C$8.40.
Wall Street Analyst Weigh In
Separately, TD Securities boosted their target price on KP Tissue from C$8.50 to C$9.00 and gave the stock a "hold" rating in a research report on Wednesday, August 14th.
Check Out Our Latest Stock Report on KP Tissue
KP Tissue Stock Down 4.0 %
The company has a 50 day moving average of C$8.46 and a 200 day moving average of C$8.42. The stock has a market capitalization of C$80.36 million, a price-to-earnings ratio of 14.00, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37.
KP Tissue (TSE:KPT - Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported C$0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of C$0.22 by C($0.10). The company had revenue of C$509.80 million for the quarter, compared to analysts' expectations of C$487.50 million. On average, research analysts forecast that KP Tissue Inc. will post 0.4398964 earnings per share for the current fiscal year.
KP Tissue Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 15th were paid a $0.18 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.93%. KP Tissue's dividend payout ratio (DPR) is currently 120.00%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
